Details for New Drug Application (NDA): 050587
✉ Email this page to a colleague
The generic ingredient in PRIMAXIN is cilastatin sodium; imipenem. There are sixteen drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the cilastatin sodium; imipenem profile page.
Summary for 050587
Tradename: | PRIMAXIN |
Applicant: | Merck |
Ingredient: | cilastatin sodium; imipenem |
Patents: | 0 |
Pharmacology for NDA: 050587
Mechanism of Action | Dipeptidase Inhibitors |
Suppliers and Packaging for NDA: 050587
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PRIMAXIN | cilastatin sodium; imipenem | POWDER;INTRAVENOUS | 050587 | NDA | Merck Sharp & Dohme LLC | 0006-3516 | 0006-3516-59 | 25 VIAL, SINGLE-DOSE in 1 TRAY (0006-3516-59) / 100 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 250MG BASE/VIAL;250MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
Approval Date: | Nov 26, 1985 | TE: | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;INTRAVENOUS | Strength | EQ 500MG BASE/VIAL;500MG/VIAL | ||||
Approval Date: | Nov 26, 1985 | TE: | AP | RLD: | Yes |
Expired US Patents for NDA 050587
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Merck | PRIMAXIN | cilastatin sodium; imipenem | POWDER;INTRAVENOUS | 050587-001 | Nov 26, 1985 | ⤷ Subscribe | ⤷ Subscribe |
Merck | PRIMAXIN | cilastatin sodium; imipenem | POWDER;INTRAVENOUS | 050587-002 | Nov 26, 1985 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription